Finally, our finding that plasma p-tau181 and plasma NfL did not improve Aβ-positivity stratification accuracy above and beyond the plasma Aβ42/Aβ40 was consistent with the previous studies on other AD research cohorts (Palmqvist et al., 2019b). This evidence concerns the gene NEFL and Alzheimer disease.